List view / Grid view
Avacta Life Sciences
Whitepaper: Affimer® reagents facilitate affinity chromatography purification of proteins
Purification of tag-free proteins, a vital step for many research and industrial applications...
Whitepaper: Identification of specific PD-L1 Affimer inhibitors with therapeutic potential
Affimer® proteins are unique affinity proteins that exhibit high affinity and high specificity binding across a range of reaction conditions...
Interview with Amrik Basran, Chief Scientific Officer at Avacta Life Sciences
Caroline Richards, Editor of Drug Target Review, asks Amrik Basran, Chief Scientific Officer at Avacta Life Sciences, to provide his views on Affimer® technology...
Avacta to develop Affimer reagents to reduce use of animals in research
Avacta is to develop inhibin Affimer inhibitors. Inhibition of this protein stimulates the production of greater numbers of embryos per mouse...
Rapid identification and characterisation of Affimer technology
8 October 2015 | By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...
The Science of Affimers
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
Affimers and Therapeutic Applications
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
An Introduction to Avacta Life Sciences
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...
Avacta Anti-diUbiquitin K6-linkage Affimer (44-29)
1 April 2015 | By Avacta Life Sciences
Lys-6-linked chains may be involved in DNA repair. Affimers are engineered to outperform antibodies and aptamers...
Avacta Anti-diUbiquitin K33-linkage Affimer (48-1)
1 April 2015 | By Avacta Life Sciences
Lys-33-linked chains are believed to be involved in kinase modification. Affimers are engineered to outperform antibodies and aptamers...
Avacta Anti-diUbiquitin K48-linkage Affimer (36-16)
1 April 2015 | By Avacta Life Sciences
Lys-48-linked chains are involved in protein degradation via the proteasome. Affimers are engineered to outperform antibodies and aptamers...
Avacta Anti-Human SUMO1 Affimer (HS1-A1)
1 April 2015 | By Avacta Life Sciences
A ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer...
An Introduction to Affimers – the engineered antibody alternative
This video provides an introduction to custom Affimers, as well as and overview of the benefits and ease of implementation into current processes...



















